Replies to post #93421 on Biotech Values

[DewDiligence]

ABT/AZN drop development of Certriad, the combo pill consisting of Crestor + TriLipix:

http://finance.yahoo.com/news/Abbott-and-AstraZeneca-End-prnews-1709401615.html?x=0&.v=1

The FDA issued a CRL in Mar 2010 (#msg-48400231), but neither company ever disclosed what the issues were.